OPTHF
Optimi Health Corp. News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 1,
"returned": 1,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "052448e9-b832-4d48-9648-b45fbf7491fc",
"title": "Optimi Health Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University's Institute for Psychedelic Research By Investing.com",
"description": "Optimi Health Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University's Institute for Psychedelic Research",
"keywords": "",
"snippet": "VANCOUVER, British Columbia, May 09, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed GMP ps...",
"url": "https://www.investing.com/news/press-releases/optimi-health-receives-export-permit-from-health-canada-to-ship-mdma-to-tel-aviv-universitys-institute-for-psychedelic-research-93CH-3431644",
"image_url": "https://i-invdn-com.investing.com/news/news_headline_rolled_69x52._800x533_L_1419494221.jpg",
"language": "en",
"published_at": "2024-05-09T12:29:20.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "OPTHF",
"name": "Optimi Health Corp.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Defensive",
"match_score": 83.91171,
"sentiment_score": 0.335,
"highlights": [
{
"highlight": "VANCOUVER, British Columbia, May 09, 2024 (GLOBE NEWSWIRE) -- <em>Optimi</em> <em>Health</em> <em>Corp</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(CSE: OPTI) (OTCQX: <em>OPTHF</em>) (FRA: 8BN), a leading Health Canada licensed GMP psychedelics pharmaceutical manufacturer, specializing in controlled substances such as botanical psilocybin and MDMA, is pleased to report a significant update to its collaboration with The Institute for Psychedelic Research at Tel Aviv University (IPR-TLV).",
"sentiment": 0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "\"Partnering with IPR-TLV and shipping MDMA to Israel marks a significant advancement for Optimi,\" said Bill Ciprick, CEO of <em>Optimi</em> <em>Health</em>. \"As a supplier with the ability to produce GMP psychedelic pharmaceuticals on demand, we are proud to be furthering our mission of supporting psychedelic research and innovation on a global scale.",
"sentiment": 0.8807,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Optimi</em> <em>Health</em> Chief Financial Officer, Jacob Safarik, commented, \"Obtaining an Export Permit to ship controlled substances globally involves a meticulous process that demands collaboration from various stakeholders.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "See disclosureor\n\nFor media inquiries, please contact Michael Kydd:\n\[email protected]\n\nFor investor inquiries, please contact: [email protected]\n\nwww.optimihealth.ca\n\nABOUT OPTIMI (CSE: OPTI) (OTCQX: <em>OPTHF</em>) (FRA: 8BN)\n\n<em>Optimi</em> <em>Health</em> <em>Corp</em>. is a leading Health Canada licensed psychedelics pharmaceutical manufacturer, specializing",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Optimi</em> <em>Health</em> Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University's Institute for Psychedelic Research By Investing.com",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "OPTHF",
"total_documents": 1,
"sentiment_avg": 0.33500000834465027
}
]
}
Other details
Exchange
- Over-the-counter Markets
- equity
- Consumer Defensive
- us